✦ LIBER ✦

Efficacy and safety of cerivastatin 0.8 mg versus pravastatin 40 mg for treatment of dyslipidaemia

✍ Scribed by A Rubinstein; A.D Marais; W.B Szostak; D Colquhoun; I Keber; J.P Werba; M Bertolami; D Stolero; S Tal

Book ID: 119434532
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 139 KB
Volume: 151
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(00)80337-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Efficacy and Safety of Cerivas

Long-Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia

✍ Jonathan Isaacsohn; William Insull; Evan Stein; Peter Kwiterovich; Ma Patrick; R 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 842 KB

Efficacy and safety of 0.8 mg dosage of

Efficacy and safety of 0.8 mg dosage of cerivastatin, a novel HMG-CoA reductase inhibitor

✍ Stein, E.; Isaacsohn, J.; Stoltz, R.; Mazzu, A.; Liu, M.-C.; Lane, C.; Heller, A 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

CAVEAT: A comparison of cerivastatin 0.4

CAVEAT: A comparison of cerivastatin 0.4 mg and 0.8 mg with atorvastatin 10 mg and 20 mg in patients with combined (type IIB) dyslipidaemia

✍ Ma, P.; Hegele, R.; Yale, J.F.; Schwartz, B. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Efficacy and safety of pravastatin 40 mg

Efficacy and safety of pravastatin 40 mg/day in Japanese patients with heterozygous familial hypercholesterolemia

✍ H. Mabuchi; Y. Matsuzawa; Y. Saito; A. Gunji 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Efficacy and Safety of Adding Fenofibrat

Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapy

✍ Michel Farnier; Jean Ducobu; Leszek Bryniarski 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Efficacy and Safety of Olmesartan Medoxo

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension

✍ Prof Roberto Fogari, Stefano Taddei, Merete Holm-Bentzen, Jacek Baszak, Lorenzo 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 189 KB